Therefore, we combined the LINC00173 expression level with the TNM stage to construct a comprehensive prognostic model, which classified NPC patients into the following three groups: a high‐risk group with high LINC00173 expression and advanced TNM stage; an intermediate‐risk group with high LINC00173 expression or advanced TNM stage; and a low‐risk group with low LINC00173 expression and early TNM stage. The gene discussed is LINC00173; the disease is nasopharyngeal carcinoma.